# iRegene raises an undisclosed amount in equity financing

On 2026-07-14, according to Xiniu Data, iRegene completed equity financing for an undisclosed amount. Investors were Suzhou Xingzexingyongxinxing Medical Industrial Investment Fund Management Partnership (Limited Partnership). The company is a developer of chemically induced cell therapy drugs.



Canonical: https://uniquebase.ai/news/c838fcca-df27-403e-a3e7-19bac83ce4dc
Stable identifier: c838fcca-df27-403e-a3e7-19bac83ce4dc
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:23:00.748Z

## Connected profiles

- [Suzhou Xingzexingyongxinxing Medical Industrial Investment Fund Management Partnership (Limited Partnership)](/institutions/suzhou-xingzexingyongxinxing-medical-industrial-investment-fund-management-partnership-limited-partnership)
- [iRegene](/companies/UB-C5987)

## Sources

- No source links are available for this profile.